DNA RNA and Cells
25 February 2016
Dicerna Reports Progress with GalNAc-DsiRNA-EX-Conjugates25 February 2016
Daiichi Sankyo Announces Commencement of Clinical Trials in Japan for Duchenne Muscular Dystrophy Treatment24 February 2016
Regen BioPharma, Inc. Completes Preclinical Experimentation for Its siRNA NR2F6 Checkpoint Inhibitor24 February 2016
ZIOPHARM Announces First Patient Treated in the Dose Escalation Portion of the Phase 1 Study of Ad-RTS-hIL-12 for Advanced Glioma22 February 2016
Mesoblast’s cell therapy increases survival in children with acute graft versus host disease17 February 2016
RG-101 Interim Analysis Shows 97% Response at 8 Week Follow-Up17 February 2016
bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma17 February 2016
Progress in fighting cancer and infections with T cell therapy17 February 2016
Bone Therapeutics Treats 12 Patients without Safety Concerns in ALLOB® Phase IIA Spinal Fusion Trial16 February 2016
Mesoblast cell therapy shows clinical benefit in first cohort of patients with biologic refractory rheumatoid arthritis10 February 2016
Daiichi Sankyo Joint Development Product Designated Under “SAKIGAKE Designation System”9 February 2016
Seres Therapeutics Announces Publication of Positive SER-109 Phase 1b/2 Study Results in The Journal of Infectious Diseases9 February 2016
Oncotelic presents the synergy of OT-101 (a late stage TGF beta inhibitor) and a chemotherapy agent8 February 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I4 February 2016
Juventas Therapeutics Enrolls First Patient in Phase 2 Gene Therapy Clinical Trial for Treatment of Advanced Peripheral Artery Disease3 February 2016
LCT Receives Ethics Approval for Phase IIb Parkinson’s Trial1 February 2016
Lion Biotechnologies Announces Allowance of IND Application to Begin Clinical Trials in Cervical, Head and Neck CancersNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports